Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT04061356
Eligibility Criteria:
Inclusion Criteria:
* Male or Female, aged ≥18 years.
* A confirmed, clinician made diagnosis of Interstitial Lung Disease (ILD) supported by evidence of ILD on a CT chest scan recorded at any time.
* OR a clinician suspected or confirmed Lung Cancer, with or without asthma and/or COPD
* OR a healthy volunteer with no known history of lung disease (defined as no current clinical diagnosis of, or be receiving treatment for, a lung disease).
* Willing and able to give informed consent for participation in the study.
Exclusion Criteria:
* Existing co-morbidities that may prevent them from performing spirometry or other study measurements (at the discretion of the clinical investigator).
* Known other lung, chest wall, neuromuscular, or cardiac disease or abnormality (including end-stage disease or cancer) that would confound symptom scores and spirometry.
* In the opinion of the clinical investigator, participant could be put at risk of harm by having to perform any of the study procedures.
* Unable to comprehend the study and provide informed consent, e.g. insufficient command of English in the absence of someone to adequately interpret.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04061356
Study Brief:
Protocol Section:
NCT04061356